Mar. 27 at 10:28 AM
WATCHLIST MAR 27 2025
$VTS Vitesse Energy Announces It Has Received Exemptive Relief From The Applicable Canadian Securities Authorities Regarding Future Filing Requirements
$SVRA Savara Completes Submission Of Biologics License Application (To FDA For MOLBREEVI As Treatment For Autoimmune Pulmonary Alveolar Proteinosis
$OXBR Oxbridge Re shares are trading higher after the company reported a year-over-year increase in FY24 financial results.
$LNTH CytoSite Bio Announces Agreement With Lantheus For Granzyme B Targeted PET Imaging Radiotracer For Immunotherapy Assessment; CytoSite Will Lead Initial Clinical Development With Lantheus Having An Exclusive Option To Acquire Worldwide Development And Commercialization Rights To The Radiotracer
$SLNO Soleno Therapeutics Says FDA Approved VYKAT XR Extended-Release Tablets For Treatment Of Hyperphagia In Adults And Children 4 Years Of Age And Older With Prader-Willi Syndrome